Incidence and Risk Factors for Post-Intravitreal Injection Endophthalmitis in a Modified Operating Room Setting-Reference-Cited by-同舟云学术

Incidence and Risk Factors for Post-Intravitreal Injection Endophthalmitis in a Modified Operating Room Setting

Published:2018-10-10 Issue:8 Volume:27 Page:1314-1321
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Zarei Mohammad¹,Karkhaneh Reza¹,Mahmoudzadeh Razieh¹,Salabati Mirataollah¹,Nabavi Amin¹,Yaseri Mehdi²,Najibzadeh Ehsan¹,Roohipoor Ramak¹,Riazi Esfahani Mohammad¹,Khodabande Alireza¹,Ghassemi Fariba¹,Ebrahimiadib Nazanin¹,Khojasteh Hasan¹,Modjtahedi Bobeck S.³⁴

Affiliation:

1. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Ophthalmology, Southern California Permanente Medical Group, Baldwin Park, California, USA

4. Eye Monitoring Center, Kaiser Permanente Southern California, Baldwin Park, California, USA

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2018.1526306

Reference31 articles.

1. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

2. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

3. Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

4. INCIDENCE OF PRESUMED ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION PERFORMED IN THE OPERATING ROOM

5. INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. POSTINTRAVITREAL INJECTION AND POSTCATARACT EXTRACTION ENDOPHTHALMITIS VISUAL OUTCOMES BY ORGANISM;Retina;2024-09

2. Pars plana vitrectomy versus intravitreal antibiotics for endophthalmitis management following intravitreal anti‐VEGF agents: A meta‐analysis;Acta Ophthalmologica;2023-06-21

3. Impact of Coronavirus Disease 2019 Pandemic on the Epidemiology of Intravitreal Injections;Journal of Current Ophthalmology;2022-10

4. Post-intravitreal injection endophthalmitis pattern during the COVID-19 pandemic with implementation of patients’ masking;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-06-09

5. Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings;JAMA Ophthalmology;2021-10-01